spacer

Tuesday, 27 September 2011 20:00

CoreRx Continues to Increase Staff - Adds BD Director

CoreRx has appointed William Beck as Director, Business Development, covering the Northeast. Mr. Beck will be responsible for all business development activities in support of the company’s strategic growth and development plans for this region.

Mr. Beck has a diversified background encompassing over 30 years in marketing, sales, research and development, with experience in challenging domestic and international markets including custom API synthesis. He has held business development positions at numerous CROs, including AAI Pharma Services. Most recently, he was business development manager at Synthetech, Inc.

About CoreRx, Inc.

CoreRx focuses on supporting and streamlining the drug development process for biotechnology and pharmaceutical innovators by offering services such as pre-formulation/formulation development, analytical development, clinical manufacturing and validation engineering. We have a proven track record and extensive expertise providing comprehensive drug development services to biotechnology and pharmaceutical companies worldwide.

CoreRx, Inc. is a cGMP-compliant contract research and manufacturing facility with expertise in analytical services, formulation development and contract pharmaceutical manufacturing. From its inception in 2006, CoreRx has been dedicated to solving scientific problems and providing expert pharmaceutical services to businesses required to meet the growing demand of pharmaceutical companies.  The facility is conveniently located in Tampa, Florida, a few miles from the Tampa International Airport.

Keep on top of new developments and throughout the drug development industry by following us on Twitter www.twitter.com/CoreRx. For more detailed information about us, visit www.corerxpharma.com.

Last modified on Friday, 27 January 2012 22:45

source logos